Overview
Supraventricular bradyarrhythmias involve abnormally slow heart rhythms originating above the ventricles, often leading to symptoms such as fatigue, dizziness, and syncope due to inadequate cardiac output 1.Diagnosis
Clinical symptoms including syncope, near syncope, and fatigue
Electrocardiogram (ECG) demonstrating bradycardia (heart rate typically <60 bpm)
Exclusion of other causes through history, physical examination, and possibly echocardiography 1Management
First-line treatments:
- Pharmacological management with atropine or glycopyrrolate (doses vary based on clinical response)
Adjunctive treatments:
- Transdermal scopolamine patch for symptomatic relief in patients where pacing is not indicated (e.g., terminally ill or severely demented patients) 1Special Populations
Elderly: Transdermal scopolamine may be considered for symptomatic relief in elderly patients where pacing is not feasible 1
Comorbidities: Management strategies may need to be tailored based on coexisting conditions, though specific guidance is limited in the provided abstracts 1Key Recommendations
Consider transdermal scopolamine for symptomatic relief in patients with supraventricular bradyarrhythmia who are not candidates for cardiac pacing (e.g., terminally ill or severely demented). (Evidence: Expert opinion) 1
Evaluate and manage underlying causes through comprehensive clinical assessment and appropriate diagnostic testing. (Evidence: Expert opinion) 1
Tailor pharmacological interventions like atropine or glycopyrrolate based on individual patient response and clinical need. (Evidence: Weak) 1References
1 Mukerji V, Alpert MA, Sanfelippo JF, McElroy BB, King PD. Treatment of chronic symptomatic supraventricular bradyarrhythmias with transdermal scopolamine. Chest 1988. link